US Patent 7462624 Purinone derivatives as HM74a agonists
Patent 7462624 was granted and assigned to Incyte on December, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Anlai Wang0
Brian Metcalf0
Changsheng Zheng0
Chu-Biao Xue0
Ganfeng Cao0
Ke Zhang0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+261 characters)
Article
Patent abstract
The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07462624 Purinone derivatives as HM74a agonists US Patent 7462624 Purinone derivatives as HM74a agonists
Infobox
Patent Number
074626240
Patent Number
74626240
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074626240
Date of Patent
December 9, 2008
0Patent Application Number
117669900
Date Filed
June 22, 2007
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07462624 Purinone derivatives as HM74a agonists
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07462624
Date of patent
December 9, 2008
Patent application number
11766990
Date Filed
June 22, 2007
Patent primary examiner
Find more entities like US Patent 7462624 Purinone derivatives as HM74a agonists
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
